OmniAb, Inc. (OABI)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · OABI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance dropped from the top half to the bottom half of its industry over the past month — the reason to own it has weakened.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 25.3% |
| Our one-year growth estimate | diamond | 14.5% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 10.8 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 116 industry peers · Company calendar date is not available
OABI — earnings in line
Dated 2026-10-30
Results of Operations and Financial Condition. On October 30, 2026, OmniAb, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2026. A copy of this press release is furnished herewith as Exhibit 99.1 to this report. In accordance with General Instruction B.2. of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of…
Why it matters: OmniAb opened xPloration to all customers in October. Meeting its revenue range would show early demand for the wider launch.
Supportive ifReported xPloration revenue for 2026 is $2 million to $3 million.
Worry ifReported 2026 xPloration revenue is below $2 million, or the company cuts its range.
Why it matters: OmniAb raised its year-end cash range twice in 2026. Meeting the latest floor would confirm that the cash outlook improved.
Supportive ifYear-end cash and cash equivalents are at least $53 million, the low end of the latest range.
Worry ifYear-end cash and cash equivalents fall below $53 million, or OmniAb cuts its $53 million to $57 million range.
Why it matters: Revenue rose from $10.3 million to $31.8 million in the first nine months. Much of the gain came from milestones, so the year-end result tests whether the higher outlook holds.
Supportive ifFull-year 2026 revenue is at least $35 million, the low end of the latest range.
Worry ifFull-year 2026 revenue is below $35 million, or the company cuts its $35 million to $39 million range.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$232 on $10,000 · ±2.3% | How much price usually moves either way. |
| Bad day | $561 loss on $10,000 · 5.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,704 loss on $10,000 · 37.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.